Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Provectus Pharmaceuticals (PVCT) just unveiled an announcement.
Bruce Horowitz has stepped down from his roles at Provectus Biopharmaceuticals, including his position on the Board and as Chief Operating Officer. A termination agreement was reached, wherein Horowitz will receive a total payment of $508,000 if paid by June 30, 2024, and he has agreed to a five-year standstill on company securities. Following his departure, the company has appointed Dominic Rodrigues as the chief operations consultant and principal executive officer. Rodrigues brings a wealth of experience from various industries and academia, and will receive a monthly payment of $20,000 for his services, with the contract operating on a month-to-month basis.
For an in-depth examination of PVCT stock, go to TipRanks’ Stock Analysis page.